Home

People come first at Ferring Pharmaceuticals

we believe in the power of people and research

we go where ideas and research takes us!

 

Watch the video

 

 

Ferring Global

The Ferring Group is a privately owned company which was first founded in 1950 in Sweden by Dr. Frederik Paulsen. It has a global turnover in excess of 1.2 billion (Euros) with ambitions to reach turnover of 3 billion by 2020.

Ferring now has a presence in more than 60 countries and a workforce in excess of 6,500 employees worldwide. Our presence spans America, Europe, the Middle East and Africa, and Asia Pacific. It currently has production sites in ten countries (Argentina, China, Czech Republic, Denmark, Germany, Israel, Mexico, Scotland, Switzerland, India and the USA). Ferring also has its own Research and Development centres (in China, Denmark, India, Israel and the USA). Ferring currently distributes its products in more than 90 countries.

Further information about the Ferring Group is available at www.ferring.com.

Ferring UK

Ferring in the UK was established in 1975. Today Ferring UK employs around 100 employees and has an annual turnover of £73m.

Business is focused on the following therapy areas:

• Reproductive Health
• Gastroenterology
• Urology
• Endocrinology
• Men’s Health

 

The Ferring Mission Statement

Driven by its entrepreneurial spirit and enabled by a decentralised organisational setup, Ferring will harness its world-class competencies in science and business with other innovative technologies to create solutions for patients and doctors.
By developing an understanding of people’s needs, we will deliver personalised healthcare solutions, integrating pharmaceutical products with diagnostics, data, devices, education and support services to optimise health outcomes.

Ferring will be the world-leading, most trusted healthcare company in reproductive medicine and maternal health, and a leader in specialty areas within gastroenterology and urology. Each of us at Ferring will contribute to providing innovative solutions to help people live better lives. We will devote significant research and development investment to new therapeutics, life cycle management and next generation healthcare solutions.

We are, and continue to be, part of a transparent and aligned company. We strive to best address the needs of patients, stakeholders and customers by collaborating across functions, experimenting and sharing our practices, and continuously learning. We are always guided by the Ferring Philosophy.

The Ferring Philosophy

Our philosophy, ‘People come first at Ferring’, is the cornerstone of our business and our approach to CSR. It sets out what we expect of ourselves (towards our patients, employees, physicians and partners), as well as the expectations we have of those who make up the Ferring community.

Building on our philosophy’s firm foundation, we define our CSR statement.

Our Corporate Social Responsibility

Corporate Social Responsibility (CSR) is about how we as a Company operate in an ethical and sustainable way and deal with our environmental and social impacts.

Our Therapeutic Areas

As a leader in gastroenterology, Ferring has more than 35 years’ experience in research and providing the right therapies to optimise treatment outcomes for mild to moderate Ulcerative Colitis patients. Ferring is also committed to deepening our understanding of the role of the human microbiome.

We are committed to helping people become parents and to finding innovative, personalised healthcare solutions in reproductive medicine. We offer a portfolio of products for women undergoing infertility treatment.

Ferring has been supplying medicines in obstetrics for over 20 years. The current product portfolio has treatments for induction of labour and prevention of uterine atony in women following Caesarian section.

Ferring has over 50 years of experience in Urology. Our main focus in Urology is on the treatment of prostate cancer and other men’s health-related conditions such as erectile dysfunction. Ferring also provides treatments for nocturnal enuresis and nocturia.

The current situation with Coronavirus (Covid-19) is confusing and uncertain for everyone, but perhaps especially for those couples who have had treatment cancelled / postponed or were expecting to start fertility treatment soon.

Fertility Network UK is providing information, advice and support to patients at https://fertilitynetworkuk.org/  or phone numbers 01424 732361 or 0121 323 5025. Fertility Network is one of the patient organisations Ferring provides with funding sponsorship.

This page is not intended for patients or for members of the general public. It is only intended to be used by healthcare professionals.

OK

Cette page n'est pas destinée aux patients ou au grand public. Il est uniquement destiné à être utilisé par des professionnels de santé.

OK

Ik bevestig dat ik een professionele zorgverlener ben of een zakelijke relatie heb met Ferring Pharmaceuticals

OK

Ez az oldal nem betegeknek, vagy nagyközönségnek szól. Az oldalt kizárólag egészségügyi szakemberek használhatják.

OK

Ta strona nie jest przeznaczona dla pacjentów ani dla ogółu odwiedzających. Ta strona stworzona jest dla pracowników sektora ochrony zdrowia.

OK

Эта страница не предназначена для пациентов или для широкой публики. Она предназначена только для медицинских работников.

OK